June 16, 2021
Servier and PRISM BioLab enter drug discovery collaboration for a novel target
PRISM BioLab provides PepMetics® (peptide mimetic small molecules) Technology for generating Hit and Lead compounds against...
Read More
November 4, 2020
PRISM Biolab and Merck enter multi-project drug discovery collaboration
PRISM Biolab provides The PRISM Library, proprietary library of peptide mimetic small molecules for screening against...
Read More
September 10, 2020
InveniAI and PRISM BioLab Initiate a Collaboration
InveniAI and PRISM BioLab Initiate a Collaboration for the Development of Therapeutic Candidates for Treatment of...
Read More
June 8, 2020
PRISM Biolab and Boehringer Ingelheim enter multi-project drug discovery collaboration
PRISM Biolab provides The PRISM Library, proprietary library of peptide mimetic small molecules for screening against...
Read More
November 12, 2018
Notice of Our Merger
PRISM Pharma Co.,Ltd. (“Pharma”) and its wholly owned subsidiary, PRISM BioLab Co.,Ltd.(“BioLab”), have merged as of...
Read More